~19 spots leftby Apr 2026

PFIcope+EMI for Alcoholism

AM
Overseen byAna M Abrantes, Ph.D.
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Butler Hospital
Disqualifiers: Substance use disorder, Psychotic disorder, Suicidal ideation
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests a treatment that combines personalized advice with supportive text messages for young adults in a psychiatric program who drink to cope with negative emotions. The goal is to provide real-time support to manage emotions and reduce drinking.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the PFIcope+EMI treatment for alcoholism?

Research shows that using personalized feedback and real-time assessments, like those in PFIcope+EMI, can help people reduce their drinking by understanding their motivations and self-confidence. Studies have found that daily tracking of motivation and self-efficacy (belief in one's ability to succeed) can predict drinking behavior, suggesting that these methods can be effective in treating alcohol use disorder.12345

Is PFIcope+EMI safe for humans?

The research articles provided do not contain specific safety data for PFIcope+EMI or its related interventions. They focus on understanding behavior and relapse in alcohol use disorder using ecological momentary assessment, but do not address safety concerns.12678

How is the PFIcope+EMI treatment for alcoholism different from other treatments?

The PFIcope+EMI treatment is unique because it combines personalized feedback on coping motives with real-time interventions delivered in everyday situations, helping individuals manage their drinking by addressing specific high-risk scenarios and improving coping strategies.910111213

Research Team

AM

Ana M Abrantes, Ph.D.

Principal Investigator

Butler Hospital/Alpert Medical School of Brown University

Eligibility Criteria

This trial is for young adults aged 18-25 who drink alcohol heavily at least three times a week and use it to cope with negative feelings. They must have symptoms of anxiety or depression, own a smartphone, but not be currently suicidal or have severe substance use disorders (except for alcohol, cannabis, or nicotine) or psychotic conditions.

Inclusion Criteria

Owns a smartphone capable of downloading EMA app.
I am currently experiencing significant symptoms of anxiety and/or depression.
Self-reported use of coping motive (mean of 2+ on coping subscale of MDMQ-R, indicating they drink to cope at least 'some of the time')
See 2 more

Exclusion Criteria

History of psychotic disorder or current psychotic symptoms as assessed by research staff via SCID
Current DSM-5 diagnosis of moderate/severe substance use disorder (other than alcohol, cannabis, or nicotine) as assessed by research staff via SCID
I do not have thoughts of harming myself or others.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a 6-week PFIcope+EMI intervention, including personalized feedback sessions, EMA monitoring, and tailored EMI text messages.

6 weeks

Follow-up

Participants are monitored for alcohol outcomes and psychiatric symptomatology at 6-weeks, 12-weeks, and 6-months to determine outcomes and feasibility/acceptability.

6 months

Treatment Details

Interventions

  • Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI) (Behavioral Intervention)
  • Personalized Normative Feedback (Behavioral Intervention)
Trial OverviewThe study tests an intervention combining personalized feedback on drinking habits with real-time support through text messages against just receiving personalized feedback. The goal is to see if this approach can reduce the need to drink due to stress and overall alcohol consumption over six weeks.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: PFIcope+EMIExperimental Treatment1 Intervention
The 6-week PFIcope+EMI includes: 1) an in-person personalized feedback session to present feedback on problems with drinking to cope, discuss the individual's use of alcohol to cope, and generate coping skills messages to be used in the EMI intervention; 2) EMA to monitor affect, intention to drink, coping skills usage, alcohol use, drinking to cope post-discharge; 3) tailored text messages (EMI) based on EMA (individualized coping skills messages when NA and intention to drink are reported).
Group II: PNFActive Control1 Intervention
Participants in the PNF condition will receive normative feedback only on their alcohol use.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Butler Hospital

Lead Sponsor

Trials
133
Recruited
16,700+
Matt Schnur profile image

Matt Schnur

Butler Hospital

Chief Executive Officer

Doctor of Pharmacy from Duquesne University

Dr. Monique Butler profile image

Dr. Monique Butler

Butler Hospital

Chief Medical Officer since 2018

MD from Wayne State University, MBA from the University of Tennessee

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+
Dr. George F. Koob profile image

Dr. George F. Koob

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Chief Executive Officer since 2014

PhD in Neurobiology from the Scripps Research Institute

Dr. Patricia Powell profile image

Dr. Patricia Powell

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Chief Medical Officer since 2015

MD from an accredited institution

Findings from Research

Dynamical systems modeling was used to analyze behavior change mechanisms in individuals with alcohol use disorder, revealing that these mechanisms are complex and interact dynamically over time.
The study found that patients who successfully reduced their drinking exhibited similar patterns of behavior change, highlighting the effectiveness of personalized approaches in understanding treatment outcomes.
Dynamical Systems Modeling to Identify a Cohort of Problem Drinkers with Similar Mechanisms of Behavior Change.Bekele-Maxwell, K., Everett, RA., Shao, S., et al.[2023]
In a study of 43 alcohol-dependent outpatients using Ecological Momentary Assessment, it was found that negative affect is linked to increased temptation to drink, suggesting that emotional states can trigger cravings for alcohol.
Lapsers (those who drank against treatment goals) reported higher levels of craving and lower motivation to abstain compared to abstainers, indicating that monitoring these factors could help professionals support patients in maintaining sobriety.
Affect, motivation, temptation, and drinking among alcohol-dependent outpatients trying to maintain abstinence: An Ecological Momentary Assessment study.Waters, AJ., Schoenmakers, TM., Snelleman, M., et al.[2023]
The study involved 96 treatment-seeking problem drinkers who completed daily surveys over 7 weeks, revealing that daily changes in motivation and self-efficacy significantly predicted drinking behavior in the following 24 hours.
The findings highlight the potential of ecological momentary assessment (EMA) and intensive longitudinal data (ILD) methods to enhance research on alcohol use disorder (AUD) treatment, although some expected moderating factors did not show support.
Within-person associations between daily motivation and self-efficacy and drinking among problem drinkers in treatment.Morgenstern, J., Kuerbis, A., Houser, J., et al.[2018]

References

Dynamical Systems Modeling to Identify a Cohort of Problem Drinkers with Similar Mechanisms of Behavior Change. [2023]
Affect, motivation, temptation, and drinking among alcohol-dependent outpatients trying to maintain abstinence: An Ecological Momentary Assessment study. [2023]
Within-person associations between daily motivation and self-efficacy and drinking among problem drinkers in treatment. [2018]
Examining motivational interviewing's effect on confidence and commitment using daily data. [2020]
Profiles of confidence and commitment to change as predictors of moderated drinking: a person-centered approach. [2021]
Mean Versus Variability: Disentangling Stress Effects on Alcohol Lapses Among Individuals in the First Year of Alcohol Use Disorder Recovery. [2022]
Assessing real-time positive subjective effects of alcohol using high-resolution ecological momentary assessment in risky versus light drinkers. [2023]
Ecological momentary assessment of the effects of craving and affect on risk for relapse during substance abuse treatment. [2018]
Relationship between posttreatment drinking and alternative responses to high-risk situations proposed during treatment by problem drinkers. [2019]
Interactions between adaptive coping and drinking to cope in predicting naturalistic drinking and drinking following a lab-based psychosocial stressor. [2021]
Coping mediates the effects of cognitive-behavioral therapy for alcohol use disorder among out-patient clients in Project MATCH when dependence severity is high. [2018]
Targeted naltrexone treatment of early problem drinkers. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Psychopathological symptoms, defense mechanisms and time perspectives among subjects with alcohol dependence (AD) presenting different patterns of coping with stress. [2020]